Capital Change – Placement & Institutional Entitlement

Capital Change Notice for Placement and Institutional Entitlement Offer Ryman Healthcare Limited (Ryman) (NZX: RYM) provides the attached Capital Change Notice pursuant to NZX Listing Rule 3.13.1. This notice relates to the issue of an aggregate total of 236,409,637 new ordinary shares (New Shares) under the institutional placement (Placement) and the institutional component (Institutional Entitlement Offer) of the accelerated non-renounceable entitlement offer (Entitlement Offer), as announced on 24 February 2025 (Offer). Aggregate gross proceeds of approximately $721 million have been raised under the Placement and Institutional Entitlement Offer, with approximately $280 million being raised under the retail component of the Entitlement Offer (Retail Entitlement Offer). Placement participation and allocations For the purpose of NZX Listing Rule 4.17.9(c), and having regard to the objectives which supported Ryman's choice of offer structure (being the Placement and Entitlement Offer): (a) Ryman invited existing eligible institutional shareholders in each of the material jurisdictions to participate in the Placement, together with other institutional investors and brokers representing eligible retail investors. (b) Ryman’s objectives for allocations under the Placement were primarily to: (i) treat existing eligible shareholders fairly, taking into account their pro-rata allocation across the Placement and the Entitlement Offer; (ii) use best efforts to allocate to eligible institutional shareholders a minimum of their pro-rata equivalent of the Placement component of the Offer or any lower amount bid for; and (iii) following allocations to eligible institutional shareholders in accordance with paragraph (b)(ii) above, allocate taking into consideration existing shareholdings, potential to be a long term and supportive shareholder and levels of support for the Offer (including the size and timeliness of demand). Final allocation decisions were made by Ryman together with Craigs Investment Partners Limited, Forsyth Barr Limited and Jarden Securities Limited, in their capacity as Joint Lead Managers of the Offer. There were no significant exceptions or deviations from the objectives and criteria set out above. All existing eligible institutional shareholders who bid for their pro-rata allocation of the Placement were allocated at least that amount of New Shares. Retail Entitlement Offer Ryman reminds shareholders that the Retail Entitlement Offer closes at 5.00pm (NZDT) on Monday, 10 March 2025. The Retail Entitlement Offer is available to eligible retail shareholders at the same offer price as the Institutional Entitlement Offer of $3.05 per New Share. Eligible retail shareholders can apply at ryman.capitalraise.co.nz. Eligible retail shareholders who have taken up all of their Entitlements in full may apply for additional New Shares, up to a maximum amount of New Shares equal to 75% of their entitlements, which will assist those who wish to do so to mitigate any dilution by the Placement (subject to available shortfall). ENDS Authorised by: Morgan Powell General Counsel About Ryman: Ryman Healthcare was founded in Christchurch in 1984 and owns and operates 49 retirement villages in New Zealand and Australia. Ryman villages are home to 15,300 residents, and the company employs 7,700 staff. Contacts: For investor relations information contact Hayden Strickett, Head of Investor Relations, on +64 27 303 1132 or hayden.strickett@rymanhealthcare.com For media information contact Camille Middleditch on +64 28 422 3472 or camille.middleditch@rymanexternal.com Currency: Unless otherwise stated, all references to “$” are to the New Zealand dollar. Not an offer of securities in the United States: This announcement has been prepared for publication in New Zealand and may not be released or distributed in the United States. This announcement does not constitute an offer, invitation or recommendation to subscribe for or purchase any security or financial product and neither this announcement nor anything attached to this announcement shall form the basis of any contract or commitment. In particular, this announcement does not constitute an offer to sell, or the solicitation of an offer to buy, securities in the United States or any other jurisdiction in which such an offer would be illegal. Any securities described in this announcement have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”) or the securities laws of any state or other jurisdiction of the United States and may not be offered or sold, directly or indirectly, in the United States except in transactions exempt from, or not subject to, the registration requirements of the U.S. Securities Act and the securities laws of any state or other jurisdiction of the United States. The New Shares to be offered and sold in the Retail Entitlement Offer may only be offered and sold outside the United States in “offshore transactions” (as defined in Rule 902(h) under the U.S. Securities Act) in reliance on Regulation S under the U.S. Securities Act.